Prognostic Value of an Integrin-Based Signature in Hepatocellular Carcinoma and the Identification of Immunological Role of LIMS2.

MLA

Ye, Fengning, et al. “Prognostic Value of an Integrin-Based Signature in Hepatocellular Carcinoma and the Identification of Immunological Role of LIMS2.” Disease Markers, vol. 2022, Sept. 2022, p. 7356297. EBSCOhost, https://doi.org/10.1155/2022/7356297.

APA

Ye, F., Le, H., He, F., Tu, H., Peng, D., & Ruan, S. (2022). Prognostic Value of an Integrin-Based Signature in Hepatocellular Carcinoma and the Identification of Immunological Role of LIMS2. Disease Markers, 2022, 7356297. https://doi.org/10.1155/2022/7356297

Chicago

Ye, Fengning, Hao Le, Fan He, Hao Tu, Dengfa Peng, and Sini Ruan. 2022. “Prognostic Value of an Integrin-Based Signature in Hepatocellular Carcinoma and the Identification of Immunological Role of LIMS2.” Disease Markers 2022 (September): 7356297. doi:10.1155/2022/7356297.